(NYSE: BAX) Baxter International's forecast annual revenue growth rate of 1.97% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 9.17%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.34%.
Baxter International's revenue in 2026 is $11,320,000,000.On average, 17 Wall Street analysts forecast BAX's revenue for 2026 to be $5,924,932,459,776, with the lowest BAX revenue forecast at $5,732,805,988,800, and the highest BAX revenue forecast at $6,200,210,441,040. On average, 17 Wall Street analysts forecast BAX's revenue for 2027 to be $6,037,006,234,512, with the lowest BAX revenue forecast at $5,790,134,048,688, and the highest BAX revenue forecast at $6,351,019,391,376.
In 2028, BAX is forecast to generate $6,215,704,511,280 in revenue, with the lowest revenue forecast at $5,956,953,538,272 and the highest revenue forecast at $6,572,068,126,800.